RNU6-835P

Across TCGA pan-cancer cohorts, RNU6-835P RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RNU6-835P data layer.

The strongest signal is observed in thymoma (THYM), where higher RNU6-835P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-835P expression acts as an unfavorable survival marker.

THYM, STAD, and PAAD are the cancer types where RNU6-835P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	OS	Tertile	All	0.169	0.931	<.001	81	view →
STAD	OS	Tertile	IV	0.052	0.496	<.001	63	view →
PAAD	OS	Tertile	All	0.207	0.594	<.001	54	view →
GBM	DFS	Tertile	All	0.052	0.242	.011	9	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

RNU6-835P–THYM (OS)

Open the THYM breakdown →